Xofluza in Australia: Cost and Availability
The price of Xofluza (baloxavir marboxil) in Australia varies depending on the specific dosage, the pharmacy, and whether it is covered by the Pharmaceutical Benefits Scheme (PBS).
How much does Xofluza cost in Australia?
Without PBS subsidy, the cost of Xofluza can be significant. For example, a single 80 mg dose may cost several hundred Australian dollars. Patients should consult their doctor and pharmacist for the most up-to-date pricing information and to determine eligibility for PBS listing.
Is Xofluza available on the PBS in Australia?
Xofluza is listed on the PBS for specific indications. To be eligible for PBS subsidy, a patient must meet certain criteria as determined by their prescribing doctor and the PBS guidelines. This typically involves treatment for uncomplicated influenza in individuals aged 12 years and older, who have had symptoms for no more than 48 hours.
Where can I buy Xofluza in Australia?
Xofluza is a prescription-only medication and can only be obtained from licensed pharmacies in Australia upon presentation of a valid prescription from a registered medical practitioner.
How does Xofluza work?
Xofluza is an antiviral medication that works by inhibiting the cap-dependent endonuclease activity of the influenza virus polymerase acidic protein. This enzyme is crucial for viral replication. By blocking this enzyme, Xofluza prevents the virus from making new copies of itself, thereby reducing the duration and severity of influenza symptoms.
What is the recommended dosage for Xofluza?
The recommended dosage for Xofluza in Australia for uncomplicated influenza is typically a single oral dose of 80 mg. The specific dosage may be adjusted by a healthcare professional based on individual patient factors and the nature of the infection.
Who is Xofluza approved for in Australia?
In Australia, Xofluza is approved for the treatment of acute uncomplicated influenza in individuals aged 12 years and older who have been symptomatic for no more than 48 hours. It is important for patients to consult with their doctor to confirm if Xofluza is an appropriate treatment option for their specific situation.
What are the side effects of Xofluza?
Common side effects associated with Xofluza may include diarrhea, bronchitis, nausea, vomiting, sinusitis, and headache. Less common but potentially serious side effects can also occur. Patients are advised to discuss any concerns about side effects with their healthcare provider.
How does Xofluza compare to other flu treatments?
Xofluza offers a single-dose treatment regimen, which can be a key differentiator compared to other antiviral flu medications that may require multiple doses over several days. The mechanism of action of Xofluza also differs from neuraminidase inhibitors, another class of influenza antivirals.
When does the patent for Xofluza expire in Australia?
Information regarding the specific patent expiry dates for Xofluza in Australia can be found through specialized resources. DrugPatentWatch.com is a valuable source for tracking pharmaceutical patent information, including expiry dates and patent litigation [1].
Sources:
1. DrugPatentWatch.com